Three years after the release of PPACA and a year and a half after the release of the Proposed Rule, it is
now time for pharmaceutical manufacturers to reengage an
d reevaluate their preparation for the Final
Rule. With the tentative release date of January 2014 on the horizon, CIS will host the
webinar
entitled
“
The CMS AMP Final Rule: It is Time to Re
-
engage
”
on Wed
nesday, September 25 featuring
Chris
Cobourn
, Senior Vice President, Commercial Compliance, and
Erika Scholl
, Senio
r Manager,
Government
Programs Consulting. They
will discuss the various unique
components in the Proposed Rule and their
projected impact on statutory pricing calculations as well as overall business. For each component,
they
will
look at the
potential ou
tcomes in the Final Rule, their likelihood of inclusion
in the Final Rule, and
what pharmaceutical manufacturers
can do to plan and budget for the changes that will come.
L
earn
more about this session in
Cobourn's latest entry on the CIS blog
.

The
second webinar entitled “
Bona Fide Service Fees: Lessons Learned
” will be held on
Thursday,
September 26
featuring
Rick Moore
, Senior Manager, US Commercial Compliance, and
Larri Short
, Partner at Arent Fox LLC.
They plan to go over the
key takeaways from previous BFSF reviews and outline how compani
es can embed
policies and processes into their commercial and GP operations to ensure continued, current and effective
analysis.

All webinars will be held from 2:00
-
3:15pm EST. For a complete list of upcoming webinars and to submit
questions in advance,
visit
http://cis
-
partners.com/category/insight/webinars
-
insight/
.